Denise Sheehan

1.0k total citations
9 papers, 261 citations indexed

About

Denise Sheehan is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Denise Sheehan has authored 9 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Oncology and 2 papers in Surgery. Recurrent topics in Denise Sheehan's work include Prostate Cancer Treatment and Research (6 papers), Cancer Treatment and Pharmacology (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Denise Sheehan is often cited by papers focused on Prostate Cancer Treatment and Research (6 papers), Cancer Treatment and Pharmacology (3 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). Denise Sheehan collaborates with scholars based in United Kingdom, Switzerland and United States. Denise Sheehan's co-authors include Nicholas D. James, Malcolm Crundwell, Isabel Syndikus, Peter Jenkins, Emma Hall, Jean Tremlett, Robert Huddart, Syed A. Hussain, Christine Rawlings and Rebecca Lewis and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Denise Sheehan

9 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Denise Sheehan United Kingdom 5 144 111 64 51 45 9 261
Kathryn E. Marqueen United States 11 117 0.8× 61 0.5× 20 0.3× 70 1.4× 17 0.4× 20 220
Charlien Berghen Belgium 11 62 0.4× 279 2.5× 17 0.3× 46 0.9× 56 1.2× 39 366
Clare Cruickshank United Kingdom 9 55 0.4× 121 1.1× 12 0.2× 27 0.5× 18 0.4× 18 241
Brenda Sussman United States 6 49 0.3× 295 2.7× 13 0.2× 27 0.5× 34 0.8× 7 321
Mary Achim United States 12 76 0.5× 271 2.4× 14 0.2× 48 0.9× 42 0.9× 23 323
K.R. Durrant United Kingdom 7 85 0.6× 103 0.9× 18 0.3× 129 2.5× 66 1.5× 14 279
Eva E. Schaake Netherlands 12 59 0.4× 208 1.9× 10 0.2× 91 1.8× 30 0.7× 26 317
C. Surcel Romania 9 65 0.5× 268 2.4× 11 0.2× 43 0.8× 17 0.4× 19 294
Andrea Hiltz Canada 3 68 0.5× 362 3.3× 7 0.1× 88 1.7× 39 0.9× 4 407
Stijn H. de Vries Netherlands 10 110 0.8× 300 2.7× 33 0.5× 68 1.3× 32 0.7× 13 346

Countries citing papers authored by Denise Sheehan

Since Specialization
Citations

This map shows the geographic impact of Denise Sheehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Sheehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Sheehan more than expected).

Fields of papers citing papers by Denise Sheehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Sheehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Sheehan. The network helps show where Denise Sheehan may publish in the future.

Co-authorship network of co-authors of Denise Sheehan

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Sheehan. A scholar is included among the top collaborators of Denise Sheehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Sheehan. Denise Sheehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hall, Emma, Syed A. Hussain, Núria Porta, et al.. (2022). Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial. European Urology. 82(3). 273–279. 59 indexed citations
2.
James, Nicholas D., Hannah Rush, Noel W. Clarke, et al.. (2020). 611O Abiraterone acetate plus prednisolone for hormone-naïve prostate cancer (PCa): Long-term results from metastatic (M1) patients in the STAMPEDE randomised trial (NCT00268476). Annals of Oncology. 31. S509–S509. 14 indexed citations
3.
Parker, Chris, Nicholas D. James, Chris Brawley, et al.. (2018). Radiotherapy (RT) to the primary tumour for men with newly-diagnosed metastatic prostate cancer (PCa): Survival results from STAMPEDE. Annals of Oncology. 29. viii722–viii723. 1 indexed citations
4.
5.
Boegemann, Martin, Martin Hatzinger, Els Everaert, et al.. (2017). Real-world treatment with abiraterone acetate in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 35(6_suppl). 239–239. 1 indexed citations
6.
Huddart, Robert, Emma Hall, Syed A. Hussain, et al.. (2013). Randomized Noninferiority Trial of Reduced High-Dose Volume Versus Standard Volume Radiation Therapy for Muscle-Invasive Bladder Cancer: Results of the BC2001 Trial (CRUK/01/004). International Journal of Radiation Oncology*Biology*Physics. 87(2). 261–269. 97 indexed citations
7.
James, Nicholas D., Matthew R. Sydes, Malcolm D. Mason, et al.. (2012). Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial. The Lancet Oncology. 13(5). 549–558. 68 indexed citations
8.
James, Nicholas D., Matthew R. Sydes, Malcolm D. Mason, et al.. (2012). Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: First results from STAMPEDE (MRC PR08, CRUK/06/019), a randomized controlled trial.. Journal of Clinical Oncology. 30(5_suppl). 26–26. 3 indexed citations
9.
Thurairaja, Ramesh, Richard Pocock, Malcolm Crundwell, et al.. (2008). Brachytherapy for advanced prostate cancer bleeding. Prostate Cancer and Prostatic Diseases. 11(4). 367–370. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn E. Marqueen Breakdown of academic impact, for papers by Charlien Berghen Breakdown of academic impact, for papers by Clare Cruickshank Breakdown of academic impact, for papers by Brenda Sussman Breakdown of academic impact, for papers by Mary Achim Breakdown of academic impact, for papers by K.R. Durrant Breakdown of academic impact, for papers by Eva E. Schaake Breakdown of academic impact, for papers by C. Surcel Breakdown of academic impact, for papers by Andrea Hiltz Breakdown of academic impact, for papers by Stijn H. de Vries
Rankless by CCL
2026